GNH USA

Europe — EMA

Iricryn

GNH USA supplies Iricryn (Bimatoprost), a prostaglandin analog for open‑angle glaucoma, ocular hypertension and eyelash hypotrichosis.

Bimatoprost

Request sourcing

1
Pack/s

What is Bimatoprost?

Bimatoprost, the active ingredient in Iricryn, is a prostaglandin analog presented as a 0.01% w/v ophthalmic solution for ocular use. It treats open‑angle glaucoma, ocular hypertension and can promote eyelash growth in patients with hypotrichosis.

GNH USA supplies Iricryn as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Bimatoprost used for?

Bimatoprost is a prostaglandin analog used to lower intraocular pressure in ocular conditions.

Open‑angle glaucoma: reduces intraocular pressure to prevent optic nerve damage. Ocular hypertension: lowers eye pressure to reduce the risk of progression to glaucoma. Hypotrichosis of eyelashes: promotes longer, darker eyelashes to improve appearance.

What are the side effects of Bimatoprost?

Bimatoprost may cause ocular and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects: - Eye redness - Eye itching - Eyelash darkening - Eyelash lengthening - Eye irritation - Blurred vision

Serious or Rare Side Effects: - Iridocyclitis - Severe conjunctival hyperemia - Periorbital skin darkening - Vision loss - Allergic reaction (including anaphylaxis) - Macular edema

What precautions apply to Bimatoprost?

Before using Iricryn, consider the following precautions.

Pregnancy: Category C – use only if potential benefit justifies potential risk. Breastfeeding: Caution – limited data, evaluate risk versus benefit. Contraindications: Do not use in patients with active intraocular inflammation. Monitoring: Regular intraocular pressure checks are recommended. Drug interactions: Review concomitant ocular medications for additive pressure‑lowering effects. Store at room temperature: keep in the original container, protect from light and moisture.

What does Bimatoprost interact with?

Bimatoprost can interact with other ocular or systemic agents; monitor patients accordingly.

Major Interactions (Avoid): - Non‑steroidal anti‑inflammatory eye drops: may reduce efficacy. - Systemic carbonic anhydrase inhibitors: additive intraocular pressure lowering may cause hypotony. - Other prostaglandin analogues: increased risk of ocular hyperemia.

Moderate Interactions (Monitor Closely): - Topical beta‑blockers: combined effect on intraocular pressure, monitor closely. - Corticosteroid eye drops: may counteract pressure‑lowering effect. - Contact lens wear: may increase drug absorption; advise removal before instillation.

Frequently asked questions

What is Iricryn used for?+
Iricryn contains bimatoprost and is prescribed to lower intraocular pressure in patients with open‑angle glaucoma or ocular hypertension, and it is also indicated to treat hypotrichosis of the eyelashes, promoting longer, darker lashes. The medication is administered as an eye drop and should be used under the direction of an eye‑care professional.
How does bimatoprost work?+
Bimatoprost acts as an agonist at the prostaglandin F (FP) receptors in the eye’s ciliary body. Activation of these receptors enhances the uveoscleral outflow of aqueous humor, which reduces intraocular pressure. In hair follicles, the same receptor stimulation promotes the growth phase of eyelashes, resulting in increased length, thickness, and pigmentation.
What is the usual dose of Iricryn?+
The dosing regimen for Iricryn is determined by the prescribing ophthalmologist. Typically, one drop is instilled into the affected eye(s) once daily in the evening, but the exact dose and timing are individualized based on the patient’s condition, response, and tolerance. Patients should follow the prescriber’s instructions precisely.
Is Iricryn safe during pregnancy or breastfeeding?+
Bimatoprost is classified as pregnancy category C, indicating that risk cannot be ruled out and it should only be used if the potential benefit justifies the potential fetal risk. Limited data are available for breastfeeding; therefore, caution is advised and the prescriber should evaluate the risk‑benefit ratio before use.
How do I order Iricryn from GNH USA?+
To request Iricryn, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA supplies hospitals, pharmacies and procurement teams worldwide, and will ask for trade or institutional credentials. The team then provides pricing, availability, shipping details and any necessary import documentation.
How does Iricryn compare with other glaucoma eye drops?+
Iricryn (bimatoprost) belongs to the prostaglandin analog class, which generally offers once‑daily dosing and potent intraocular pressure reduction. Compared with beta‑blocker drops, prostaglandin analogues often have a better tolerability profile and greater efficacy in many patients, though individual response varies and choice depends on clinical factors and patient preference.
How should I store Iricryn?+
Iricryn should be stored at room temperature, below 25 °C, in the original container. Keep the bottle tightly closed, protect it from light and moisture, and avoid freezing. Do not refrigerate unless otherwise directed by the pharmacist. Discard any solution that appears discolored or contains particles.
How is Iricryn administered?+
Iricryn is applied as an ophthalmic solution. The patient should wash hands, tilt the head back, and gently pull down the lower eyelid to create a pocket. One drop is placed into the conjunctival sac of the prescribed eye(s) without touching the tip to the eye or lashes. The eye should be closed gently for a few minutes to aid absorption.
What are the most serious risks to watch for with Iricryn?+
Although uncommon, serious adverse events can include severe ocular inflammation such as iridocyclitis, significant conjunctival hyperemia, periorbital skin darkening, macular edema, and vision loss. Patients should seek immediate medical attention if they experience eye pain, worsening redness, sudden vision changes, or signs of an allergic reaction such as swelling or difficulty breathing.
Who should not use Iricryn?+
Iricryn is contraindicated in patients with active intraocular inflammation, such as uveitis or iritis, and in those who have demonstrated hypersensitivity to bimatoprost or any component of the formulation. Caution is also advised for individuals with a history of severe ocular side effects, pregnant women unless clearly needed, and patients using certain interacting ocular medications. The prescriber should assess suitability before initiating therapy.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Bimatoprost
Route
Ocular Use
Manufacturer
Trb Chemedica Sas
Origin
EU

Related products